Sasa veitchii extract reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet. 2017

Hiroki Yoshioka, and Mihoko Mori, and Hirohisa Fujii, and Tsunemasa Nonogaki
College of Pharmacy, Kinjo Gakuin University, Nagoya, Japan.

The aim of this study was to investigate the therapeutic effect of Sasa veitchii leaf extract (SE) on features of obesity induced by a high-fat diet (HFD), such as hyperglycemia, insulin resistance, and inflammatory response. Four-week-old male ddY mice were freely fed HFD or control normal diet for 12 weeks; half was given SE in addition twice per day in weeks 8-12. Glucose and insulin intolerance were estimated, and body weight measured, weekly throughout the study. Following the experiment, the mice were fasted for 16 h, euthanized, and plasma was collected. Liver and epididymal adipose tissue was collected and weighed. Treatment with SE significantly decreased body weight, adipose tissue weight, plasma glucose, insulin, leptin, and tumor necrosis factor α compared with HFD groups, and markedly reduced the impairment of glucose and insulin tolerance in obese mice. Furthermore, hepatic steatosis and hepatic insulin receptor substrate were improved by treatment with SE. Our findings demonstrate that SE may reduce obesity-induced glucose and insulin tolerance, not only by suppressing inflammatory responses but also by improving insulin signaling.

UI MeSH Term Description Entries
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008297 Male Males
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D010936 Plant Extracts Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. Herbal Medicines,Plant Extract,Extract, Plant,Extracts, Plant,Medicines, Herbal
D005234 Fatty Liver Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS. Liver Steatosis,Steatohepatitis,Steatosis of Liver,Visceral Steatosis,Liver Steatoses,Liver, Fatty,Steatohepatitides,Steatoses, Liver,Steatoses, Visceral,Steatosis, Liver,Steatosis, Visceral,Visceral Steatoses
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D059305 Diet, High-Fat Consumption of excessive DIETARY FATS. Diet, High Fat,Diets, High Fat,Diets, High-Fat,High Fat Diet,High Fat Diets,High-Fat Diet,High-Fat Diets
D031787 Sasa A plant genus of the family POACEAE. Folin is the water-soluble extract from Sasa albomarginata. Sasa kurinensis is an ingredient of Sho-ju-sen, a Japanese herbal medicine. Bamboo Grass,Grass, Bamboo,Kumazasa,Sasa albomarginata,Sasa kurinensis,Bamboo Grasses,Grasses, Bamboo,Kumazasas,Sasa albomarginatas,Sasa kurinenses,Sasas,albomarginatas, Sasa,kurinenses, Sasa

Related Publications

Hiroki Yoshioka, and Mihoko Mori, and Hirohisa Fujii, and Tsunemasa Nonogaki
April 2010, Obesity (Silver Spring, Md.),
Hiroki Yoshioka, and Mihoko Mori, and Hirohisa Fujii, and Tsunemasa Nonogaki
June 2014, Nutrients,
Hiroki Yoshioka, and Mihoko Mori, and Hirohisa Fujii, and Tsunemasa Nonogaki
July 2016, Nutrition research (New York, N.Y.),
Hiroki Yoshioka, and Mihoko Mori, and Hirohisa Fujii, and Tsunemasa Nonogaki
September 2021, The Journal of nutritional biochemistry,
Hiroki Yoshioka, and Mihoko Mori, and Hirohisa Fujii, and Tsunemasa Nonogaki
November 2018, Nutrients,
Hiroki Yoshioka, and Mihoko Mori, and Hirohisa Fujii, and Tsunemasa Nonogaki
October 2020, Journal of ethnopharmacology,
Hiroki Yoshioka, and Mihoko Mori, and Hirohisa Fujii, and Tsunemasa Nonogaki
January 2012, Bioscience, biotechnology, and biochemistry,
Hiroki Yoshioka, and Mihoko Mori, and Hirohisa Fujii, and Tsunemasa Nonogaki
June 2012, Immune network,
Hiroki Yoshioka, and Mihoko Mori, and Hirohisa Fujii, and Tsunemasa Nonogaki
January 2018, PloS one,
Hiroki Yoshioka, and Mihoko Mori, and Hirohisa Fujii, and Tsunemasa Nonogaki
December 2013, Food chemistry,
Copied contents to your clipboard!